COMPANY PROFILE · UPDATED 18 NOV 2025

Twist Bioscience

Twist Bioscience is a public company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.

twistbioscience.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2013
Headcount: 775
Open roles: 31
Last raised: Post Ipo Equity · Sign in to view

TECH STACK

How Twist Bioscience builds

Extracted from Twist Bioscience’s job postings we’ve tracked

Collaboration & Productivity

Atlassian×11 Jira×6 Confluence×2 Google Workspace Smartsheet

CRM & Sales Tools

Salesforce×10 Marketo

Other Software & Platforms

Microsoft Office×3 Google Sheets×2 Adobe Creative Suite Microsoft Project NetSuite

Cloud Platforms

Amazon Web Services Microsoft Azure

DevOps & Infrastructure

Cisco Meraki Linux

Frameworks & Libraries

Metal

Analytics & BI

Microsoft Power BI

Databases

Oracle

Programming Languages

Python

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Twist Bioscience

View all 31 open roles →

FUNDING

Capital raised

Total raised

$553,110,720

Investors

+ND Capital3W PartnersARCH Overage FundArch Venture PartnersAsset Management VenturesBay City CapitalBiomatics Capital PartnersBoris NikolicCapital World InvestorsCormorant Asset ManagementDentsu VenturesDitch Plains Capital ManagementE Squared Capital ManagementFidelity InvestmentsFidelity National Information ServicesFirst Citizens BankForesite CapitalGoldenArc CapitalIlluminaIllumina VenturesJoby PritzkerKangmei Pharmaceutical Co.Merieux Equity PartnersNFT InvestmentPaladin Capital GroupReinet Investments S.C.A.Tao Venture PartnersWuXi Healthcare Ventures

Funding rounds

Post Ipo Equity
Capital World Investors
$250MFeb 8, 2022
Post Ipo Equity
$50MJan 26, 2020
Series Unknown
E Squared Capital Management
$50MApr 1, 2018
IPO
UndisclosedJan 1, 2018
Series Unknown
Biomatics Capital Partners, Reinet Investments S.C.A., Fidelity National Information Services, NFT Investment, Kangmei Pharmaceutical Co., 3W Partners, Ditch Plains Capital Management, Bay City Capital
$27MJun 13, 2017
Series Unknown
Asset Management Ventures, Dentsu Ventures
$33MMar 26, 2017
Series D
Merieux Equity Partners, Cormorant Asset Management, Fidelity Investments, Foresite Capital, Arch Venture Partners, WuXi Healthcare Ventures, Paladin Capital Group, Boris Nikolic, ARCH Overage Fund, +ND Capital, Asset Management Ventures, Illumina Ventures, GoldenArc Capital
$61MJan 18, 2016
Series C
Illumina, Fidelity Investments, Foresite Capital, Arch Venture Partners, Paladin Capital Group, Joby Pritzker, +ND Capital, Asset Management Ventures, Tao Venture Partners
$37MJun 8, 2015
Debt Financing
First Citizens Bank
$10MSep 29, 2014
Series B
Tao Venture Partners, Arch Venture Partners, Paladin Capital Group, Asset Management Ventures, +ND Capital
$26MMay 26, 2014
Series A
Arch Venture Partners, Asset Management Ventures, Paladin Capital Group
$9.1MFeb 9, 2014

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

LOCATIONS

Where they work

Twist Bioscience offices

Loading map…

Portland, OR
Quincy, MA
San Francisco, CA
South San Francisco, CA